Company Filing History:
1 out of 1,476 
1 out of 134 
Years Active: 2019
Title: Gary Peh: Innovator in Corneal Endothelial Cell Research
Introduction
Gary Peh is a notable inventor based in Singapore, recognized for his contributions to the field of biomedical research. His work primarily focuses on the enrichment and characterization of human corneal endothelial cells, which are crucial for corneal transplantation.
Latest Patents
Gary Peh holds a patent for the invention titled "Enrichment and characterization of human corneal endothelial cells (hCENC) with novel monoclonal antibody." This invention pertains to an antibody or an antigen binding portion that specifically binds to human corneal endothelial cells (hCENCs). The target of the monoclonal antibody is the cell surface-expressed Peroxiredoxin-6 (Prdx6). The patent also includes methods for determining the suitability of a cell sample for corneal transplantation, quantitative enrichment of human corneal endothelial cells from a mixture of cells, and isolating these cells from a mixture.
Career Highlights
Throughout his career, Gary Peh has worked with prominent organizations such as the Agency for Science, Technology and Research and Singapore Health Services Pte Ltd. His experience in these institutions has significantly contributed to his expertise in the field of cell biology and transplantation.
Collaborations
Gary has collaborated with several professionals in his field, including Mei Yee Vanessa Ding and Boon Hwa Andre Choo. These collaborations have enhanced his research and development efforts in corneal endothelial cell studies.
Conclusion
Gary Peh is a distinguished inventor whose work in the enrichment and characterization of human corneal endothelial cells has the potential to impact corneal transplantation significantly. His innovative approach and dedication to research continue to advance the field of biomedical science.